The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $171.92

Today's change-0.55 -0.32%
Updated October 18 2:34 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $171.92

Today's change-0.55 -0.32%
Updated October 18 2:34 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc down (U.S.)$0.55

Abiomed Inc is lower today, dropping (U.S.)$0.55 or 0.32% to (U.S.)$171.92. Shares have lost 0.43% over the last five days, but sit 2.16% below their 52-week high. This security has outperformed the S&P 500 by 13.41% during the last year.

Key company metrics

  • Open(U.S.) $172.97
  • Previous close(U.S.) $172.47
  • High(U.S.) $173.75
  • Low(U.S.) $171.91
  • Bid / Ask(U.S.) $171.92 / (U.S.) $172.11
  • YTD % change+52.57%
  • Volume102,153
  • Average volume (10-day)250,453
  • Average volume (1-month)281,398
  • Average volume (3-month)295,028
  • 52-week range(U.S.) $95.14 to (U.S.) $175.72
  • Beta0.20
  • Trailing P/E101.40×
  • P/E 1 year forward76.77×
  • Forward PEG2.74×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.70
Updated October 18 2:34 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.13%

Based on its net profit margin of 16.13%, Abiomed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2018Q4/2017Q3/2017Q2/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue132125115103
Total other revenue--------
Total revenue132125115103
Gross profit1111059686
Total cost of revenue22191917
Total operating expense99968988
Selling / general / administrative61605453
Research & development17161618
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income33292515
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax34292615
Income after tax3715159
Income tax, total-414106
Net income3715159
Total adjustments to net income--------
Net income before extra. items3715159
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3715159
Inc. avail. to common incl. extra. items3715159
Diluted net income3715159
Dilution adjustment--------
Diluted weighted average shares46454545
Diluted EPS excluding extraordinary itemsvalue per share0.820.330.340.20
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.820.330.340.20